Multimodal treatment of perianal fistulas in Crohns Disease: seton versus anti-TNF versus advancement plasty

Trial Profile

Multimodal treatment of perianal fistulas in Crohns Disease: seton versus anti-TNF versus advancement plasty

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Jan 2015

At a glance

  • Drugs Adalimumab (Primary) ; Infliximab (Primary) ; Tumour necrosis factor alpha inhibitors
  • Indications Crohn's disease; Fistula
  • Focus Therapeutic Use
  • Acronyms PISA
  • Most Recent Events

    • 14 Sep 2013 New source identified and integrated (European Clinical Trials Database: EudraCT2013-002932-25).
    • 04 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top